AG
EW icon

Ascent Group’s Edwards Lifesciences EW Stock Holding History

Ascent Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$458K Buy
5,065
+34
+0.7% +$2.85K 0.01% 551
2026
Q1 		$403K Buy
5,031
+2,003
+66% +$165K 0.01% 548
2025
Q4 		$258K Sell
3,028
-156
-5% -$12.8K 0.01% 655
2025
Q3 		$248K Sell
3,184
-15
-0.5% -$1.17K 0.01% 655
2025
Q2 		$250K Buy
+3,199
New +$239K 0.01% 628
2024
Q3 		– Sell
-2,719
Closed -$251K – 531
2024
Q2 		$251K Sell
2,719
-1,364
-33% -$121K 0.02% 455
2024
Q1 		$390K Sell
4,083
-1,745
-30% -$147K 0.03% 390
2023
Q4 		$508K Sell
5,828
-252
-4% -$17.5K 0.05% 344
2023
Q3 		$393K Sell
6,080
-10,884
-64% -$875K 0.04% 350
2023
Q2 		$1.33M Sell
16,964
-5,859
-26% -$509K 0.15% 195
2023
Q1 		$1.89M Sell
22,823
-433
-2% -$34K 0.2% 151
2022
Q4 		$1.74M Buy
23,256
+356
+2% +$27.4K 0.2% 151
2022
Q3 		$1.66M Buy
22,900
+394
+2% +$37.9K 0.2% 146
2022
Q2 		$2.26M Sell
22,506
-35
-0.2% -$3.62K 0.27% 111
2022
Q1 		$2.65M Sell
22,541
-6,697
-23% -$751K 0.31% 108
2021
Q4 		$3.29M Buy
+29,238
New +$3.41M 0.42% 70

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Ascent Group's EW Position: Q2 2026 in Review

Ascent Group increased its Edwards Lifesciences (EW) stake by 0.68% in Q2 2026, buying an estimated $2.85K and bringing the position to 5,065 shares worth $458K. The position accounts for 0.01% of the portfolio, ranked #551.

Ascent Group first reported a position in EW in Q4 2021 and has held it in 16 quarters since. The position peaked at $3.29M in Q4 2021. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Ascent Group held 5,065 shares of Edwards Lifesciences worth $458K as of Q2 2026.
  • Ascent Group bought 34 Edwards Lifesciences shares in Q2 2026, an estimated $2.85K.
  • Edwards Lifesciences made up 0.01% of Ascent Group's portfolio in Q2 2026, its #551 holding.
  • Ascent Group first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 16 quarters since.
  • Ascent Group's Edwards Lifesciences position peaked at $3.29M in Q4 2021.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.